Wells Fargo
MBX

Wells Fargo’s MBX Biosciences MBX Stock Holding History

Wells Fargo’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
28,313
+17,551
+163% +$613K ﹤0.01% 3794
2026
Q1 		$321K Sell
10,762
-21,169
-66% -$720K ﹤0.01% 4394
2025
Q4 		$1.01M Buy
31,931
+20,176
+172% +$490K ﹤0.01% 3967
2025
Q3 		$206K Buy
11,755
+812
+7% +$10.9K ﹤0.01% 4917
2025
Q2 		$125K Buy
10,943
+4,966
+83% +$50.6K ﹤0.01% 5068
2025
Q1 		$44.1K Buy
5,977
+133
+2% +$1.41K ﹤0.01% 5443
2024
Q4 		$108K Buy
+5,844
New +$125K ﹤0.01% 5170

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Wells Fargo's MBX Position: Q2 2026 in Review

Wells Fargo increased its MBX Biosciences (MBX) stake by 163% in Q2 2026, buying an estimated $613K and bringing the position to 28,313 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #3794.

Wells Fargo first reported a position in MBX in Q4 2024 and has held it in 7 quarters since. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Wells Fargo held 28,313 shares of MBX Biosciences worth $1.56M as of Q2 2026.
  • Wells Fargo bought 17,551 MBX Biosciences shares in Q2 2026, an estimated $613K.
  • MBX Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3794 holding.
  • Wells Fargo first reported a position in MBX Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.